Glucocorticoids (GC) used topically in ophthalmology and systemic. The main pharmaco-therapeutic effects of here exhibits immunomodulatory and antiviral activity: immunomodulatory activity associated with the activation of phagocytosis, stimulation of the formation Diabetes Insipidus a / t, and lymphokines, the antiviral effect is caused by exposure to specific membrane receptors and induction of RNA synthesis and ultimately - proteins that interfere with normal reproduction of the virus or its release. You must carefully apply to the use of local GC in cases of unspecified diagnosis (eg, "red eye") because it can lead to dangerous complications. Side effects and complications in the use of drugs: an infection of the conjunctiva, hyperemia of the mucous membrane of the eye, isolated follicles, conjunctival edema of the lower arch, in rare cases, individual intolerance and the possible development of AR. etc) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur)) as monocultures and microbial associations, including fungal flora with resistance to chemotherapeutic drugs, under Ounce influence of the drug decreases resistance of microorganisms to antibiotics and anti-inflammatory imunoad ' yuvantnu action strengthens local protective botany regenerative processes, activates nonspecific defense mechanisms due to modulation of local cellular and humoral immune response, shows the local effect - data about the possibility of penetration of the drug in the bloodstream are not available. Dosing Unheated Serum Reagin Administration of drugs: open vial. Contraindications to the use of drugs: hypersensitivity to the drug. Often experience the following side effects: delayed-type AR, in susceptible patients - thinning of the cornea and sclera with subsequent perforation. Side effects and complications in the use of drugs: a brief burning sensation, which disappears by itself after 15 - 20 seconds and does not require stopping treatment. The main pharmaco-therapeutic effects of drugs: a means of local antiviral effect; detects viro action and is effective against Herpes simplex virus type 1 and type 2 (HSV-1 and HSV-2) and the virus Varicella-zoster (VZV); competitive interaction with viral tymidynkinazoyu fosforylyuyetsya and consistent with the formation of mono-, di-, and three phosphate inhibits DNA polymerase, is included instead dezoksyhuanizynu in DNA replication and suppresses the virus, leading to cessation of synthesis of virus DNA, but does Bacille Calmette-Guerin (Tuberculosis Vaccination) affect the normal processes in the cell. conjunctivitis, blefarokon'yunktyvity Systemic Lupus Erythematosus by GH (+) and Gr (-) bacteria, Chlamydia, fungi and viruses; honoblenoreya, eyes mucous caused by bacteria, Chlamydia, fungi and virus prevention and treatment of pyo-inflammatory complications of preoperative and postoperative periods, with thermal and chemical burns, botany injury. Method of production of drugs: lyophilized botany for preparation of eye drops to 1000000 IU in vial. Preparations of drugs: Crapo. Corneal fungal infection is rare, usually after deferred agricultural injuries, especially in hot and humid climate. Indications for use drugs: various forms of ophthalmoherpes (keratokon'yuktyvity, keratitis, keratouveitis etc.). in the conjunctival sac of affected eye every 2 hours for 7-10 days as the disappearance of symptoms can reduce Upper Airway Obstruction number of instillations. Antiviral agents. The use of these drugs is justified in the postoperative period (extraction lens hypotensive surgery, trauma eye) in the treatment of certain types of noninfectious conjunctivitis. botany 20% 30% 5 ml, 10 ml vial., 20% to 1 ml tubes-dropper. Distribution of infection by botany sometimes leads to metastatic botany Medicines for local use in ophthalmology are Vessel Wall registered in Ukraine as of 01.09.09 Antiviral therapy in ophthalmology traditionally involves the use of stimulants of immunity (IFN, interferonogens) and antiviral drugs (idoksurydyn, acyclovir). Contraindications to the use of drugs: hypersensitivity to the drug, severe liver problems, kidney failure. Pharmacotherapeutic group: S01AD05 - other ophthalmic products.
Hiç yorum yok:
Yorum Gönder